Jiménez TJP

Language: Spanish
References: 10
Page: 125-127
PDF size: 366.39 Kb.

ABSTRACT

Hepatocellular carcinoma is the most common primary hepatic neoplasia and its pronostic is related with the stage in which the diagnostic is made. Its strong increase in the incidence in the last years has made it the fifth most common neoplasia worldwide, probably because the etiologic factors as Hepatitis Virus B and C, alcohol and toxins. The diagnosis is based in screening tests in the chirrotic patients with complementary imaging tests and the measure of alpha-fetoprotein seric levels. The treatment is determined by the gravity of the hepatopathy and the stage of the tumor.

REFERENCES

1. Aguitre, I et al. Estado actual del hepatocarcinoma y perspectivas futuras. JANO. 2010.

2. Arguello, P et al Hepatocarcinoma: patología maligna de mal pronóstico Rev Col Gastroenterol 2003; 18:3.

3. Bruix, J et al. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208-1246

4. European Organisation for Research and Treatment of Cancer. Clinical Practice Guidelines: Management of Hepatocellular carcinoma. Journal of Hepatology, 2012; 56: 908-943

5. El Sarag, HB The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Int Med. 2004; 139: 817-823

6. Fattovich, G et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004; 127: S35-S50.

7. Gonzalez-Huezo, M. Carcinoma hepatocellular Revista de Gastroenterología de México. 2013; 78: 108-110.

8. Heiken, JP. Distinguishing benign from malignant liver tumors. Cancer Imaging. 2007;7: S1-S14.

9. Linares, A et al. Algortimo diagnóstico y terapéutico del carcinoma hepatocelular. Oncología. 2004; 27 (4): 223-229

10. Mazzafero, V et al Liver trasplantation for the treatment of small hepatocelular carcinomas in patients with cirrosis. N Engl J Med. 1996; 334: 693.699